cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Xencor Inc
3 own
5 watching
Current Price
$24.53
$0.76
(3.2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,046.03M
52-Week High
52-Week High
28.96000
52-Week Low
52-Week Low
16.49000
Average Volume
Average Volume
0.5M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
107.3906
iconMarket Capitalization1,046.03M
icon52-Week High28.96000
icon52-Week Low16.49000
iconAverage Volume0.5M
iconDividend Yield--
iconP/E Ratio107.3906
What does the Xencor Inc do?
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. It develops its antibody product candidates to treat autoimmune and allergic diseases, cancer, and other conditions. The company's product candidates include XmAb5871, an immune inhibitor, which is in Phase II clinical trials for the treatment of autoimmune diseases; XmAb7195, an immune inhibitor that is in Phase I clinical for use in treating asthma and allergic diseases; XmAb14045, a bispecific oncology candidate, which is in phase I clinical trials for the treatment of acute myeloid leukemia; and XmAb13676 that is in phase I clinical trials for the treatment of B-cell malignancies. Its product candidates also comprise XmAb5574/MOR208, which is in Phase II clinical trials for the treatment of non-Hodgkin lymphomas and chronic lymphocytic leukemia; and XmAb13551 that is in preclinical trials used for the treatment of multiple myeloma. The company has license agreement with Amgen Inc. and MorphoSys Ag to develop and commercialize bispecific antibody product candidates; and development and manufacturing services agreement with Catalent Pharma Solutions LLC. Xencor, Inc. was founded in 1997 and is headquartered in Monrovia, California.
Read More
How much money does Xencor Inc make?
News & Events about Xencor Inc.
Zolmax
11 months ago
Xencor, Inc. (NASDAQ:XNCR Get Rating) CEO Bassil I. Dahiyat sold 33,497 shares of the businesss stock in a transaction dated Wednesday, June 21st. The shares were sold at an average price of $26.19, for a total transaction of $877,286.43. Following the completion of the sale, the chief executive ...
Zolmax
11 months ago
Shares of Xencor, Inc. (NASDAQ:XNCR Get Rating) have received a consensus recommendation of Buy from the eleven research firms that are presently covering the firm, Marketbeat reports. Ten research analysts have rated the stock with a buy recommendation and one has assigned a strong buy ...
Business Wire
1 year ago
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today presented new preclinical data generated from engineered CD28 bispecific antibodies targeting the solid tumor antigens...
InvestorPlace
1 year ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio. The post 7 Biotech Stocks to Buy for 100% Returns appeared first on InvestorPlace...
Zolmax
1 year ago
Xencor, Inc. (NASDAQ:XNCR Get Rating) Equities research analysts at Wedbush issued their Q1 2024 earnings per share (EPS) estimates for Xencor in a note issued to investors on Friday, February 24th. Wedbush analyst D. Nierengarten anticipates that the biopharmaceutical company will post earnings of...
Frequently Asked Questions
Frequently Asked Questions
What is Xencor Inc share price today?
plus_minus_icon
Can Indians buy Xencor Inc shares?
plus_minus_icon
How can I buy Xencor Inc shares from India?
plus_minus_icon
Can Fractional shares of Xencor Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Xencor Inc stocks?
plus_minus_icon
What is today’s traded volume of Xencor Inc?
plus_minus_icon
What is today’s market capitalisation of Xencor Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Xencor Inc?
plus_minus_icon
What percentage is Xencor Inc down from its 52-Week High?
plus_minus_icon
What percentage is Xencor Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$24.53
$0.76
(3.2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00